NEW YORK—NYU Langone Medical Center, a three-campus, 789-bed institution, has received an $84 million National Institutes of Health grant to conduct a comparative-effectiveness study to investigate when angioplasty and stenting are most appropriate for patients with coronary artery disease and when medical therapy should be the first-line approach. Called the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches, or ISCHEMIA, the research is being funded by the NIH's National Heart, Lung and Blood Institute and will include more than 150 medical centers in the U.S. as well as sites in 33 other countries, according to a medical center news release. Eight thousand patients who have stable ischemic heart disease will participate, according to the release. NYU Langone's Cardiovascular Clinical Research Center will coordinate the trial, which will study whether early invasive strategy—in this case, cardiac catheterization followed by medical therapy and lifestyle changes—improves quality of life more so than beginning treatment with medical therapy and reserving invasive procedures for when conservative medical therapy fails. “The medical community agrees further study is necessary to better determine the need for an invasive strategy and the value of revascularization when treating this patient population,” Dr. Judith Hochman, study chairwoman and clinical chief of NYU Langone's division of cardiology, said in the release. “With the NIH grant, we have the opportunity to collaborate with other cardiology thought leaders from around the country and world who share our urgency in learning more about what therapies offer optimal outcomes for patients in the most cost-effective manner.”
Regional News/Northeast: NYU medical center gets $84 million grant
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.